VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.verified

VIAP

Price:

$0.0005

Market Cap:

$10.28K

VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabetes. The company's drug development pipeline includes VIA-3196, a Phase-1 ready liver-directed thyroid hormone receptor (THR) beta agonist that targets dyslipidemia, such as high LDL cholesterol, high triglycerides, and elevated Lp(a); Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor, which is in...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2007-06-06

Stock Exchange

OTC

Ticker

VIAP

The Enterprise Value as of December 2025 (TTM) for VIA Pharmaceuticals, Inc. (VIAP) is 13.93M

According to VIA Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.93M. This represents a change of -1.38% compared to the average of 14.12M of the last 4 quarters.

VIA Pharmaceuticals, Inc. (VIAP) Historical Enterprise Value (quarterly & annually)

How has VIAP Enterprise Value performed in the past?

The mean historical Enterprise Value of VIA Pharmaceuticals, Inc. over the last ten years is 11.63M. The current 13.93M Enterprise Value has changed 11.88% with respect to the historical average. Over the past ten years (40 quarters), VIAP's Enterprise Value was at its highest in in the December 2006 quarter at 43.12M. The Enterprise Value was at its lowest in in the September 2004 quarter at -8121471.25.

Quarterly (TTM)
Annual

Average

11.63M

Median

7.04M

Minimum

-537330.97

Maximum

43.12M

VIA Pharmaceuticals, Inc. (VIAP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VIA Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.02%

Maximum Annual Enterprise Value = 43.12M

Minimum Annual Increase = -2294.90%

Minimum Annual Enterprise Value = -537330.97

Quarterly (TTM)
Annual
YearEnterprise ValueChange
201014.74M24.94%
200911.79M-2294.90%
2008-537330.97-172.96%
2007736.45K-98.29%
200643.12M85.54%
200523.24M25.00%
200418.59M1.02%
20031.66M-27.32%
20022.28M254.58%
2001643.72K-123.13%

VIA Pharmaceuticals, Inc. (VIAP) Average Enterprise Value

How has VIAP Enterprise Value performed in the past?

The current Enterprise Value of VIA Pharmaceuticals, Inc. (VIAP) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

8.66M

5-year avg

13.97M

10-year avg

11.63M

VIA Pharmaceuticals, Inc. (VIAP) Enterprise Value vs. Peers

How is VIAP’s Enterprise Value compared to its peers?

VIA Pharmaceuticals, Inc.’s Enterprise Value is greater than OneLife Technologies Corp. (2.54M), greater than LifePoint, Inc. (-3261935.00), greater than Healthtech Solutions Inc. (3.28M), greater than InNexus Biotechnology, Inc. (3.38M), less than Trevena, Inc. (24.11M), greater than iCoreConnect Inc. (8.65M), greater than Winston Pharmaceuticals, Inc. (-1539625.00), less than Acutus Medical, Inc. (21.75M), greater than Evelo Biosciences, Inc. (3.20M), greater than Allstar Health Brands, Inc. (2.78M),

Build a custom stock screener for VIA Pharmaceuticals, Inc. (VIAP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VIA Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VIA Pharmaceuticals, Inc. (VIAP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VIA Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is VIA Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?

What is the 3-year average Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?

What is the 5-year average Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?

How does the current Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP) compare to its historical average?